Skip to main content

Clostridium Difficile

  • Chapter
  • First Online:

Abstract

Center for Disease Control (CDC) data in 2011 found the incidence of Clostridium difficile was approximately 500,000, with 29,000 deaths attributed to C. difficile infections (CDI). One third (66%) were healthcare associated. Initially thought to occur following clindamycin use (Bartlett. Ann Intern Med 145:758–64, 2006), it is now understood that most antibiotics contribute to its colonization and overgrowth, due to disruption of normal intestinal flora. CDI symptoms can be mild to severe and can have severe health impacts, especially on the elderly. Treatment includes antibiotics, rehydration, and in severe cases surgical consultation for toxic megacolon.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lessa FC, Bamberg WM, Beldavs ZF, et al. Burden of clostridium difficile infection in the United States. NEJM. 2015;372:825–34.

    Article  CAS  Google Scholar 

  2. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079–84.

    Article  CAS  Google Scholar 

  3. Hung Y, Lee J, Lin H, Liu H, Wu Y, Tsai P, et al. Clinical impact of Clostridium difficile colonization. J Microbiol Immunol Infect. 2015;48:241–8.

    Article  CAS  Google Scholar 

  4. Bartlett JG. Narrative review: the new epidemic of clostridium difficile–associated enteric disease. Ann Intern Med. 2006;145:758–64.

    Article  Google Scholar 

  5. Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017;65(12):1963–73.

    Article  Google Scholar 

  6. Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017;23(35):6500–15.

    Article  CAS  Google Scholar 

  7. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987–94.

    Article  CAS  Google Scholar 

  8. Guh A, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, et al. Risk factors of community-associated Clostridium difficile infection in adults: a case control study. Open Forum Infect Dis. 2017;4(4):1–8. https://doi.org/10.1093/ofid/ofx171.

    Article  CAS  Google Scholar 

  9. Chitnis A, Holzbauer S, Belflower R, Winston LG, Bamberg WM, Lyons C, et al. Epidemiology of community associated Clostridium difficile infection, 2009–2011. JAMA Intern Med. 2013;173(14):1359–67.

    Article  Google Scholar 

  10. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67(3):742–8.

    Article  CAS  Google Scholar 

  11. Bartlett J. Clostridium difficile infection. Infect Dis Clin N Am. 2017;31:489–95.

    Article  Google Scholar 

  12. Feher C, Mensa J. A comparison of current guidelines of five international societies on Clostridium difficile infection management. Infect Dis Ther. 2016;5(3):207–30.

    Article  Google Scholar 

  13. Clifford McDonald L, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Sammons JS, Sandora TJ, Wilcox MH. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 https://doi.org/10.1093/cid/cix1085

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexa R. Gale .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gale, A.R., Wilson, M. (2019). Clostridium Difficile. In: Graham, A., Carlberg, D.J. (eds) Gastrointestinal Emergencies. Springer, Cham. https://doi.org/10.1007/978-3-319-98343-1_101

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98343-1_101

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98342-4

  • Online ISBN: 978-3-319-98343-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics